Published Date: 26 Apr 2023
Many women may be wondering what this means for them in light of the Supreme Court's decision on Friday regarding a crucial medication used in medical abortions.
Read Full NewsIn patients with newly diagnosed fibromyalgia who have prominent symptoms of anxiety and depression, remission of depression — not pain reduction alone — determines clinical improvement.
Most ADHD coaches do not have behavioral health training, a study finds, but experts say peer support can help people navigate living with the condition.
In the long term, stereotactic body radiotherapy carries a lower risk for biochemical failure vs high-dose rate brachytherapy for men with intermediate-risk prostate cancer.
1.
For older patients with Hodgkin lymphoma, novel regimens produce high response rates.
2.
Specialized imaging improves overall prostate cancer survival by identifying benefits of salvage radiotherapy
3.
A global study demonstrates that screening for lung cancer significantly raises the long-term survival rate.
4.
Study finds higher breast cancer rates in areas with more air pollution
5.
Newly identified T-cell subtype may explain treatment-resistant childhood leukemia
1.
Survival Rate Dynamics in Hematologic and Solid Malignancies
2.
Omega-3 Fatty Acids as Molecular Adjuvants Against Chemoresistance in Breast Cancer
3.
TAR-200 in Bladder Cancer: Precision Drug Delivery Driving Oncology Advances
4.
Uncovering the Subtle Signs of Prostate Cancer: Early Detection is Key
5.
Unlocking The Power Of Cangrelor To Treat Heart Disease
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
2.
"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC
3.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks
4.
Exploring the Hospitalization Burden in Refractory and Relapsed ALL
5.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation